Kimberly Gentile Biohaven Pharmaceutical Holding CO Ltd. (BHVN) insider trading activity
Kimberly Gentile is SVP, Clinical Operations of Biohaven Pharmaceutical Holding Co Ltd.. Currently has a direct ownership of 0 shares of BHVN, which is worth approximately $0. The most recent transaction as insider was on Oct 03, 2022, when has been sold 11,653 shares (Common Shares) at a price of $148.5 per share, resulting in proceeds of $1,730,470. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
0
0%
3M change
0%
12M change
Total Value Held
$0
Kimberly Gentile Transaction History
Also insider at
KG
Kimberly Gentile
SVP, Clinical Operations
New Haven, CT